Solara Active Pharma Sciences Quarterly Results for Trading Insights

SOLARA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-10 Cr
QSept 2025
Quarterly Results

Solara Active Pharma Sciences Quarterly Results Key Highlights

  • Revenue of ₹314 Cr in Sept 2025 (+12.5% vs Mar 2025, -9.5% vs Sept 2024)
  • Net Profit of ₹-10 Cr in Sept 2025 (-400.0% vs Mar 2025, -225.0% vs Sept 2024)
  • EBITDA of ₹35 Cr in Sept 2025 (-31.4% vs Mar 2025)
  • Operating Margin of 11.0% in Sept 2025 (-6.0pp vs Mar 2025)
  • Earnings Per Share of ₹-2.36 in Sept 2025 (-153.8% vs Mar 2025)

Solara Active Pharma Sciences Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 314 279 320 347 301 12.5% -9.5%
Net Profit (₹ Cr) -10 -2 11 8 -255 - -
EBITDA (₹ Cr) 35 51 58 62 -111 - -
EPS (₹) -2.36 -0.93 2.46 2.54 -70.93 - -
Operating Margin (%) 11.0% 17.0% 18.0% 18.0% -38.0% - -

Solara Active Pharma Sciences Share Price Trend Around Quarterly Results

Visualize Solara Active Pharma Sciences's 1-year price movement across quarterly results — ideal for logging trades in Solara Active Pharma Sciences share price chart using Tickjournal. All values in ₹.

Related Pages for Solara Active Pharma Sciences

Additional stock information and data for SOLARA

Solara Active Pharma Sciences dividend policy
Solara Active Pharma Sciences share price today live chart
SOLARA FII DII holdings
Solara Active Pharma Sciences value estimation
Solara Active Pharma Sciences intrinsic price
SOLARA P/E ratio
Solara Active Pharma Sciences financial data

Profitability Ratios

Profit Margin -3.2%
EBITDA Margin 11.1%
Operating Margin 11.0%
ROE (Annual) -3.6%

Balance Sheet Highlights

Total Assets ₹2,232 Cr
Total Equity ₹1,097 Cr
Current Assets ₹729 Cr
Current Liabilities ₹191 Cr

Cash Flow Analysis

Operating Cash Flow ₹213 Cr
Investing Cash Flow ₹-37 Cr
Financing Cash Flow ₹-181 Cr
Net Cash Flow ₹-5 Cr

Current Market Data

Current Price ₹567.15
Exchange NSE
Last Updated Jan 06, 2026

Revenue Trend (₹ Cr)

Sept 2024 347
Jun 2025 320
Mar 2025 279
Sept 2025 314

Net Profit Trend (₹ Cr)

Sept 2024 8
Jun 2025 11
Mar 2025 -2
Sept 2025 -10

Operating Margin Trend (%)

Sept 2024 18.0%
Jun 2025 18.0%
Mar 2025 17.0%
Sept 2025 11.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Solara Active Pharma Sciences quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹422,330.94 Cr 1760.2 14,875 3,125 +10.8% - 21.0% 135.4
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 3936.8 3,219 591 +11.3% - 18.4% 224.4
Cipla
Sept 2025 		₹121,238.47 Cr 1530.8 7,716 1,353 +12.0% - 17.5% 91.5
Dr Reddys Laborator…
Sept 2025 		₹104,829.57 Cr 1256.2 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores